Multiple alignment comparison of the non-structural genes of three strains of equine influenza viruses (H3N8) isolated in Morocco

被引:10
作者
Boukharta M. [1 ]
Azlmat S. [2 ]
Elharrak M. [3 ]
Ennaji M.M. [1 ]
机构
[1] Laboratory of Virology, Microbiology and Quality/ETB, Faculty of Sciences and Techniques, Mohammedia, University Hassan II Mohammedia-Casablanca, PO BOX 146, Quartier Yasmina, Mohammedia
[2] Department of Biology, Instruction Military Hospital Med V Rabat, University Mohammed V Souissi, Rabat
[3] Society of Pharmaceutical and Veterinary Products, Virology Laboratory, Av Hassan II, BP 4569, Rabat
关键词
Effector domain; Equine influenza virus; Non-structural protein (NS); RNA-binding domain;
D O I
10.1186/s13104-015-1441-0
中图分类号
学科分类号
摘要
Background: Three equine influenza viruses, A/equine/Nador/1/1997(H3N8), A/equine/Essaouira/2/2004(H3N8), and A/equine/Essaouira/3/2004(H3N8), were isolated from different Equidae during local respiratory disease outbreaks in Morocco in 1997 and 2004. Their non-structural (NS) genes were amplified and sequenced. Results: The results show high homology of NS nucleotide sequences of A/equine/Nador/1/1997 with European strains (i.e., A/equine/newmarket/2/93 and A/equine/Grobois/1/1998) and clustered into the European lineage. However, NS gene of A/equine/Essaouira/2/2004(H3N8) and A/equine/Essaouira/3/2004(H3N8) strains indicated high homology with equine influenza strains that had circulated before 1990 (A/equine/Fontainbleu/1/1979(H3N8), which belonged to a pre-divergent phase Amino acid sequence comparison of the NS1 protein with reference strain A/equine/Miami/1963(H3N8) shows that the A/equine/Nador/1/1997(H3N8) strain has 12 substitutions at the residues D/24/N, R/44/K, S/48/I, R/67/Q, A/86/V, E/139/K, A/112/T, E/186/K, L/185/F, A/223/E, S/213/T and S/228/P. In both A/equine/Essaouira/2/2004(H3N8) and A/equine/Essaouira/3/2004(H3N8) strains, the NS1 sequences present one common mutation at the residue: S/228/P. Conclusion: It seems that all of these substitutions are not produced at the key residues of the RNA-binding domain (RBD) and the effector domain (ED). Consequently, we can suppose that they will not affect the potency of inhibition of cellular defences, and the virulence of the Moroccan equine strains will be maintained. © 2015 Boukharta et al.
引用
收藏
相关论文
共 33 条
  • [1] Myers C., Wilson D., Equine Influenza Virus, Clin Tech Equine Pract., 5, pp. 187-196, (2006)
  • [2] Sovinova O., Tumova B., Pouska F., Nemec J., Isolation of a virus causing respiratory disease in horses, Acta Virol, 2, pp. 52-61, (1958)
  • [3] Waddell G.H., Teigland M.B., Sigel M.M., A new influenza virus associated with equine respiratory disease, J Am Vet Med Assoc, 143, pp. 587-590, (1963)
  • [4] Timoney P.J., Equine influenza, Comp. lmmun MicrobioL infect Dis, 19, pp. 205-211, (1996)
  • [5] Barbic L., Madic J., Turk N., Daly J., Vaccine failure caused an outbreak of equine influenza in Croatia, Vet Microbiol, 133, pp. 164-171, (2009)
  • [6] Lai A.C.K., Rogers K.M., Glaser A., Tudor L., Chambers T., Alternate circulation of recent equine-2 influenza viruses (H3N8) from two distinct lineages in the United States, Virus Res, 100, pp. 159-164, (2004)
  • [7] Burnouf T., Griffiths E., Padilla A., Seddik S., Stephano M.A., Gutierrez J.M., Assessment of the viral safety of antivenoms fractionated from equine plasma, Biologicals., 32, pp. 115-128, (2004)
  • [8] Jiao P., Tian G., Li Y., Deng G., Jiang Y., Liu C., Liu W., Bu Z., Kawaoka Y., Chen H., A single-amino-acid substitution in the NS1 protein changes the pathogenicity of H5N1 avian influenza viruses in mice, J Virol., 82, pp. 1146-1154, (2008)
  • [9] Hale B.G., Randall R.E., Ortin G., Jackson D., The multifunctional NS1 protein of influenza A viruses, J Gen Virol, 89, pp. 2359-2376, (2008)
  • [10] Wang L., Suarez D.L., Pantin-Jackwood M., Mibayashi M., Garcia-Sastre A., Saif Y.M., Lee C.W., Characterization of influenza virus variants with different sizes of the Non-structural (NS) genes and their potential as a live influenza vaccine in poultry, Vaccine., 26, pp. 3580-3586, (2008)